Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy

NCT07715903 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

NIH

Sponsor class

Conditions

Colorectal Neoplasms
Neoplasms
Intrahepatic Cholangiocarcinoma
Adrenocortical Carcinoma
Metastasis, Neoplasm

Interventions

DRUG: Carfilzomib

Sponsor

National Cancer Institute (NCI)